A Phase 1 Study of Liposome Encapsulated Docetaxel (LE-DT) in Patients With Advanced Solid Tumors

Trial Profile

A Phase 1 Study of Liposome Encapsulated Docetaxel (LE-DT) in Patients With Advanced Solid Tumors

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Jun 2014

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 25 Jun 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 18 Nov 2009 Results have been presented at the joint AACR-NCI-EORTC conference, according to a NeoPharm media release.
    • 29 Apr 2009 Patient enrolment is continuing and trial completion in planned for the second quarter of 2009, as reported in a NeoPharm media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top